Utility and risk of dermatologic medications during the COVID‐19 pandemic

M Goldust, K Hartmann, A Abdelmaksoud… - Dermatologic …, 2020 - Wiley Online Library
In the era of staggering speed in development of the novel coronavirus disease (COVID‐19)
pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), we …

Infection risk of dermatologic therapeutics during the COVID‐19 pandemic: an evidence‐based recalibration

FM Ghazawi, M Lim, JP Dutz… - International journal of …, 2020 - Wiley Online Library
Recommendations were made recently to limit or stop the use of oral and systemic
immunotherapies for skin diseases due to potential risks to the patients during the current …

Immunosuppressive and immunomodulatory therapies in dermatology and coronavirus disease 2019 (COVID-19)

P Mansouri, S Farshi, N Nikkhah, NN Nobari… - Clinics in …, 2021 - Elsevier
COVID-19 infection may affect the individuals with many underlying conditions including
skin diseases. This cross-sectional study was conducted to provide an overview regarding …

[HTML][HTML] Familiar dermatologic drugs as therapies for COVID-19

M Ortega-Peña, R González-Cuevas - Actas Dermo-Sifiliográficas (English …, 2021 - Elsevier
Researchers the world over are working to find the treatments needed to reduce the
negative effects of coronavirus disease 2019 (COVID-19) and improve the current prognosis …

Contributions of dermatologists to COVID‐19 research: A brief systematic review

Y Wang, R Fang, H Zhang, K Tang… - Dermatologic …, 2020 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) has been declared a pandemic. We
conducted a systematic review to reveal the contribution of dermatologists in COVID‐19 …

Examining recommendations for the use of biologics and other systemic therapies during COVID-19: a review and comparison of available dermatology guidelines …

MB Gadarowski, EA Balogh, AM Bashyam… - Journal of …, 2022 - Taylor & Francis
Background The novel coronavirus (COVID-19) has an affinity for almost every organ
system, including the skin. This review article will compile and compare dermatology …

Systemic immunobiological, immunosuppressant, and oncologic agents for the treatment of dermatologic diseases during the SARS‐CoV‐2 (COVID‐19) pandemic …

G Paolino, SR Mercuri, P Bearzi… - Dermatologic …, 2020 - Wiley Online Library
The precision medicine era has helped to better manage patients with immunological and
oncological diseases, improving the quality of life of this class of patients. Regarding the …

Single‐center survey of biologic use for inflammatory skin diseases during the coronavirus disease 2019 pandemic

S Kado, K Kamiya, M Kishimoto… - The Journal of …, 2021 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) is caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2). The ongoing COVID‐19 pandemic has affected …

Patients with specific skin disorders who are affected by COVID‐19: what do experiences say about management strategies? A systematic review

NN Nobari, A Goodarzi - Dermatologic therapy, 2020 - Wiley Online Library
In patients with specific dermatologic disorders who are affected by new corona virus, we
know little about disease course (underlying disease and new onset infection), and the most …

The impact of immune-modulating treatments for dermatological diseases on the risk of infection with SARS-CoV-2 and outcomes associated with COVID-19 illness

N Maynard, AW Armstrong - Current Dermatology Reports, 2023 - Springer
Abstract Purpose of Review Immune-modulating treatments are used in dermatology for a
variety of conditions. The authors aim to review the data regarding the safety of these …